CLSN is fighting to get over the 1.58 hump. If it has any measure of success, these pennies will look pretty silly. Look at CPXX. In mid March, it was in the mid 1s, right where CLSN stands. It had a successful trial result and it shot up like a rocket and is close to 15 as I write. IMO, Hopeful
I added today.....I think it's possible that if we crack 1.58, we could close closer to 1.75. Breaking 1.58 could easily increase the appetite for the stock quickly, IMO. We'll see. IMO.
Just started DD, and I've had some good luck on some of the Yahoo MBs. Anyone have a quick pitch for opening a long position in CLSN? Any help would be greatly appreciated. Looks like there are some advanced trials. Any sense of the likelihood of success of these late stage trials?
Did the newest board member play a key role in the development of Avastin? . The company said that when you combine Gen 1 with avastin and doxel, tumors virtually dissappear. Hello Genentech.
90k or more volume tomorrow should keep this little streak going. Presenting the Potential of GEN-1 IL-12 Immunotherapy in Ovarian Cancer Monday at AACR will not hurt the cause either.
Always good to hear people talking about adding.
The way CLSN has traded, especially the last two days, make me think that the next few days may see a big move up here. We'll see if any fireworks start tomorrow......if it looks like it's going to start moving early tomorrow, I'm going to add to my position.
Granted they need cash and we don't know how they'll get it, but with their pipeline, only 23 million shares outstanding and a market cap of $35 million, it's seems like a pretty good risk/reward bet.
Maybe last chance in the 1.40's!
This could be last chance to buy in the 1.30's...
There's 23.5M outstanding shares. In my book, that's not very many.
If a partnership is not inked, or an outside source does not pony up some money, then there will be a fund raiser. Dilution of probably 7M - 15M shares. The pps may drop or not. If it does, it won't drop much.
When the positive news of Tdox going to market as SOC for single tumor HCC, the pps will be like a lottery ticket.
Divide 5B or 10B by 23M or 40M.
The pps will be 200 - 250 bucks easy.
Or with bad news, back in the toilet.
That's what's happening, we know it, you know it, you're not changing anyone's mind, so you should just take your BS elsewhere.